KFDA Concentrates on Top 300 Pharmaceutical Items for Quality Inspection

Under an initiative to conduct quality inspections on 2,000 pharmaceutical items for the current year, the Korea Food and Drug Administration (KFDA) announced it would concentrate on the top 300 items, in terms of their production and import levels, by classifying them as the priority-based subjects for inspections.

With considerations for available budgets, resources and infrastructures nec...